EMILY ROBERTSON: Open Payments
NPI 1316674328 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 14 payments from 6 companies in 2025. Trend: 2023 $735 · 2024 $306 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 3 | $166 |
| GENZYME CORPORATION | 4 | $93 |
| Regeneron Healthcare Solutions, Inc. | 4 | $83 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
Products named: DUPIXENT, Xhance, NUCALA, BOTOX.
Industry payments across LA — which companies pay providers there.
